Trials / Completed
CompletedNCT04908839
Validation of the French Version of the Stapesplasty Outcome Test 25 (SPOT-25)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 150 (actual)
- Sponsor
- Fondation Ophtalmologique Adolphe de Rothschild · Network
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
Inclusion (J0): * Audiometry (as part of the treatment, only for cases) * Clinical evaluation (within the framework of care, only for cases) * Passage of the French version of the SPOT-25 questionnaire Visit 1 (D0 + 3 ± 1 week): only for cases Second examination of the French version of the SPOT-25 questionnaire (re-test) either by telephone and e-mail, or during a consultation or hospitalization, if this occurs within a compatible time frame. Visit 2 (3-6 months postoperatively): only for operated patients Third examination of the French version of the SPOT-25 questionnaire either by telephone and e-mail, or during a consultation or hospitalization, if this occurs within a compatible time frame.
Detailed description
Inclusion (J0): * Audiometry (as part of the treatment, only for cases) * Clinical evaluation (within the framework of care, only for cases) * Passage of the French version of the SPOT-25 questionnaire Visit 1 (D0 + 3 ± 1 week): only for cases Second examination of the French version of the SPOT-25 questionnaire (re-test) either by telephone and e-mail, or during a consultation or hospitalization, if this occurs within a compatible time frame. Visit 2 (3-6 months postoperatively): only for operated patients Third examination of the French version of the SPOT-25 questionnaire either by telephone and e-mail, or during a consultation or hospitalization, if this occurs within a compatible time frame.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | spot-25 questionnaire | spot-25 questionnaire |
Timeline
- Start date
- 2021-09-09
- Primary completion
- 2022-04-06
- Completion
- 2022-04-06
- First posted
- 2021-06-01
- Last updated
- 2023-02-14
Locations
2 sites across 1 country: France
Source: ClinicalTrials.gov record NCT04908839. Inclusion in this directory is not an endorsement.